Meglitinides

M R21 Pill - white round

Pill with imprint M R21 is White, Round and has been identified as Repaglinide 0.5 mg. It is supplied by Mylan Pharmaceuticals Inc.

Repaglinide is used in the treatment of Diabetes, Type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-M R21-0.5 mg-White-Round
Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-M R21-0.5 mg-White-Round
Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-M R21-0.5 mg-White-Round
Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-M R21-0.5 mg-White-Round
Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-M R21-0.5 mg-White-Round

Repaglinide
Generic Name: repaglinide (oral) [ re-pag-li-nide ]
Imprint: M R21
Strength: 0.5 mg
Color: White
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Meglitinides
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Butylated hydroxyanisole, Silicon dioxide, Corn starch, Croscarmellose sodium, Calcium phosphate dibasic anhydrous, Magnesium stearate, Meglumine, Microcrystalline cellulose, Polacrilin potassium, Sodium lauryl sulfate,
Latest News
Related Drugs